Wagner A, Zett L
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1981 Dec;12(4):174-82.
The therapeutic effectiveness of several membrane stabilizing drugs was investigated on experimentally induced myotonia by 2,4-Dichlorophenoxyacetate (2,4-D) and in 20 patients with myotonia congenita. Procainamide and quinine showed a better antimyotonic effect in-vitro- as well as in-vivo-experiments on the cold blood muscle and the rat than Sparteine sulfate and Tachmaline (Ajmalin). The two last-mentioned drugs had nearly the same effect. Because of these experimental results only procainamide and sparteine sulfate were clinically used. Quinine was not used because of the well known side-effects. Mention is made of the fact, that the therapeutic effect depends on the dose or the concentration. The results support not only the theoretic considerations on the pathogenesis of myotonia but also recommend to carry out further pharmacological investigations with this method.
研究了几种膜稳定药物对2,4-二氯苯氧乙酸(2,4-D)实验性诱导的肌强直以及20例先天性肌强直患者的治疗效果。在冷血肌肉和大鼠的体外及体内实验中,普鲁卡因酰胺和奎宁比硫酸司巴丁和阿义马林(阿吗灵)表现出更好的抗肌强直作用。后两种药物的效果几乎相同。基于这些实验结果,临床上仅使用了普鲁卡因酰胺和硫酸司巴丁。由于众所周知的副作用,未使用奎宁。值得一提的是,治疗效果取决于剂量或浓度。这些结果不仅支持了关于肌强直发病机制的理论思考,还建议用这种方法进行进一步的药理学研究。